167 related articles for article (PubMed ID: 12412989)
1. Treatment of primary pulmonary hypertension.
Handa S
Intern Med; 2002 Oct; 41(10):757-8. PubMed ID: 12412989
[No Abstract] [Full Text] [Related]
2. Nebulized prostacyclin for pulmonary hypertension: a step in the right direction.
Wang A; Bashore TM
Eur Heart J; 1997 Sep; 18(9):1364-5. PubMed ID: 9458437
[No Abstract] [Full Text] [Related]
3. The status of pulmonary arterial hypertension in 2008.
Farber HW
Circulation; 2008 Jun; 117(23):2966-8. PubMed ID: 18541751
[No Abstract] [Full Text] [Related]
4. Effects and problems of continuous infusion of epoprostenol for patients with primary pulmonary hypertension.
Takahashi T; Sakuma M; Ikeda J; Nawata J; Demachi J; Kitamukai O; Shirato K
Intern Med; 2002 Oct; 41(10):784-8. PubMed ID: 12412996
[TBL] [Abstract][Full Text] [Related]
5. Treatment of pulmonary arterial hypertension.
Humbert M; Sitbon O; Simonneau G
N Engl J Med; 2004 Sep; 351(14):1425-36. PubMed ID: 15459304
[No Abstract] [Full Text] [Related]
6. [The combined use of sildenafil with epoprostenol in a patient with primary pulmonary hypertension].
Kayikçioğlu M; Can LH; Payzin S; Kültürsay H; Soydan I
Anadolu Kardiyol Derg; 2002 Sep; 2(3):262-4. PubMed ID: 12223337
[No Abstract] [Full Text] [Related]
7. [Therapy of severe pulmonary hypertension with prostacyclin and iloprost].
Matthes J; Mathen F; Herzig S; Wassermann K
Dtsch Med Wochenschr; 2001 May; 126(21):631-7. PubMed ID: 11413752
[No Abstract] [Full Text] [Related]
8. Intrapulmonary shunting in primary pulmonary hypertension: an observation in two patients treated with epoprostenol sodium.
Castro PF; Bourge RC; McGiffin DC; Benza RL; Fan P; Pinkard NB; McGoon MD
Chest; 1998 Jul; 114(1):334-6. PubMed ID: 9674493
[TBL] [Abstract][Full Text] [Related]
9. Successful transition from intravenous to inhaled prostacyclin in a patient with pulmonary hypertension and right ventricular failure.
Reddy MT; Patel H; Ventura HO
Congest Heart Fail; 2008; 14(5):285-6. PubMed ID: 18983294
[No Abstract] [Full Text] [Related]
10. Epoprostenol and nitric oxide therapy for severe pulmonary hypertension in liver transplantation.
Molmenti EP; Ramsay M; Ramsay K; Lynch K; Tillmann Hein HA; Molmenti H; Levy M; Goldstein R; Ausloos K; East C; Fasola C; Jung G; Escobar J; Klintmalm G
Transplant Proc; 2001; 33(1-2):1332. PubMed ID: 11267313
[No Abstract] [Full Text] [Related]
11. A new era in the treatment of primary pulmonary hypertension.
Bailey CL; Channick RN; Rubin LJ
Heart; 2001 Mar; 85(3):251-2. PubMed ID: 11179256
[No Abstract] [Full Text] [Related]
12. Identical twins with primary pulmonary hypertension: beraprost vs epoprostenol.
Berman Rosenzweig E; Schmitt KA; Garofano R; Barst RJ
Chest; 2004 Mar; 125(3):1157-60. PubMed ID: 15006984
[TBL] [Abstract][Full Text] [Related]
13. Vasodilators in the treatment of primary pulmonary hypertension.
Weir EK; Schremmer B
Eur Respir J; 1998 Aug; 12(2):263-4. PubMed ID: 9727771
[No Abstract] [Full Text] [Related]
14. [Pulmonary hypertension].
Olschewski H; Ghofrani A; Wiedemann R; Rose F; Enke B; Gessler T; Voswinckel R; Kohstall M; Grimminger F; Seeger W
Internist (Berl); 2002 Dec; 43(12):1498, 1501-9. PubMed ID: 12607389
[No Abstract] [Full Text] [Related]
15. [Effect of prostacycline on pulmonary circulation in pulmonary hypertension].
Szczeklik J; Nizankowski R; Ruzyłło W; Bijak A
Kardiol Pol; 1984; 27(7):607-12. PubMed ID: 6392688
[No Abstract] [Full Text] [Related]
16. The acute hemodynamic effect of IV nitroglycerin and dipyridamole in patients with pulmonary arterial hypertension: comparison with IV epoprostenol.
Sulica R; Dinh HV; Dunsky K; Fuster V; Poon M
Congest Heart Fail; 2005; 11(3):139-44; quiz 145-6. PubMed ID: 15947535
[TBL] [Abstract][Full Text] [Related]
17. The acute effects of prostacyclin on pulmonary hemodynamics in patients with pulmonary hypertension secondary to systemic sclerosis.
Menon N; McAlpine L; Peacock AJ; Madhok R
Arthritis Rheum; 1998 Mar; 41(3):466-9. PubMed ID: 9506575
[TBL] [Abstract][Full Text] [Related]
18. Prostacyclin therapy for pulmonary arterial hypertension: new directions.
Gomberg-Maitland M; Preston IR
Semin Respir Crit Care Med; 2005 Aug; 26(4):394-401. PubMed ID: 16121316
[TBL] [Abstract][Full Text] [Related]
19. [Current approach to the treatment of pulmonary arterial hypertension and our experience in the Cardiology Department of Medicine Faculty of Ege University].
Kayikçioğlu M; Kültürsay H
Turk Kardiyol Dern Ars; 2009 Dec; 37(8):580-90. PubMed ID: 20200464
[TBL] [Abstract][Full Text] [Related]
20. Treatment with epoprostenol reverts nitric oxide non-responsiveness in patients with primary pulmonary hypertension.
Ziesche R; Petkov V; Wittmann K; Kopatschka J; Stiebellehner L; Schenk P; Germann P; Röder G; Ullrich R; Block LH
Heart; 2000 Apr; 83(4):406-9. PubMed ID: 10722538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
